Caduet

Rediff.com » News » Caduet

News for Caduet

Business

Ranbaxy may get approval for multi-billion dollar drug

The long-awaited US approval for Ranbaxy Laboratories' generic version of anti-hypertension drug Diovan is likely to come this week, according to industry sources.While this could pull the company......

Pfizer, Wyeth sue Ranbaxy over drug

Pfizer, the world's largest drug company, and Wyeth have sued Daiichi Sankyo-owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeth's drug, Rapamune. Wyeth and its new......

Indian retail drug sales jump 10% amid slowdown

Retail sales of Ranbaxy Laboratories, Cipla, Nicholas Piramal, Lupin and other drug makers have jumped by over 10 per cent in the domestic market despite the sales of generics or copycat versions......

Pfizer, Ranbaxy lock horns over Caduet

Ranbaxy Laboratorieson Tuesday stood firm on its strategy of challenging patents, even as Pfizer has filed a suit against it to block the Gurgaon-based firm from going ahead with plans for a......

Faster drug passage to India

Since December last year, multinational pharmaceutical companies have launched as many as six patented drugs in India, compared with a dry patch before.With two more drugs and 4-5 vaccines set to......

Rediff News

Caduet

News for Caduet

Ranbaxy may get approval for multi-billion dollar drug

Pfizer, Wyeth sue Ranbaxy over drug

Indian retail drug sales jump 10% amid slowdown

Pfizer, Ranbaxy lock horns over Caduet

Faster drug passage to India

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS